Walleye Capital LLC Lowers Stock Position in Nu Skin Enterprises, Inc. $NUS

Walleye Capital LLC cut its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 52.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 159,478 shares of the company’s stock after selling 175,435 shares during the quarter. Walleye Capital LLC owned approximately 0.32% of Nu Skin Enterprises worth $1,274,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Inspire Investing LLC boosted its position in shares of Nu Skin Enterprises by 4.8% in the second quarter. Inspire Investing LLC now owns 48,794 shares of the company’s stock worth $390,000 after purchasing an additional 2,250 shares during the period. SummerHaven Investment Management LLC lifted its position in shares of Nu Skin Enterprises by 3.1% in the second quarter. SummerHaven Investment Management LLC now owns 82,344 shares of the company’s stock valued at $658,000 after acquiring an additional 2,484 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of Nu Skin Enterprises by 3.7% in the second quarter. Rhumbline Advisers now owns 80,119 shares of the company’s stock worth $640,000 after acquiring an additional 2,856 shares during the period. Amundi grew its position in shares of Nu Skin Enterprises by 18.8% during the first quarter. Amundi now owns 18,564 shares of the company’s stock worth $127,000 after purchasing an additional 2,941 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its stake in Nu Skin Enterprises by 18.5% during the 2nd quarter. Russell Investments Group Ltd. now owns 20,405 shares of the company’s stock valued at $163,000 after purchasing an additional 3,179 shares during the period. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Performance

NYSE NUS opened at $9.98 on Wednesday. The business’s 50 day moving average price is $10.41 and its 200-day moving average price is $9.99. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $14.62. The company has a market cap of $486.28 million, a P/E ratio of 4.58 and a beta of 1.00. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.45 and a current ratio of 2.15.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.04. The firm had revenue of $364.21 million during the quarter, compared to analysts’ expectations of $374.20 million. Nu Skin Enterprises had a net margin of 7.02% and a return on equity of 9.15%. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS and its Q4 2025 guidance at 0.250-0.350 EPS. Sell-side analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Friday, November 28th will be issued a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Friday, November 28th. Nu Skin Enterprises’s dividend payout ratio is presently 11.01%.

Analysts Set New Price Targets

NUS has been the subject of several recent analyst reports. Wall Street Zen downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. Zacks Research raised shares of Nu Skin Enterprises to a “hold” rating in a report on Tuesday, August 12th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $7.00.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.